SELLAS Life Sciences SLS
NASDAQ SLS
$11.79 +0.46 (+4.06%)
As of: Oct 2, 2026 · 10:20 AM EDT

SELLAS Life Sciences (SLS) Net Equity Issued and Repurchased (2011 - 2026)

Updated

SELLAS Life Sciences (SLS) recorded Net Equity Issued and Repurchased of $38.82 million in Q2 2026, up 822.3% from $4.21 million a year earlier but down 12.0% from the prior quarter.

Analysis

SELLAS Life Sciences (SLS) Net Equity Issued and Repurchased (2011 - 2026) Analysis & Trends

On a TTM basis, SELLAS Life Sciences' Net Equity Issued and Repurchased came in at $129.25 million as of Jun 30, 2026; for FY2025, it was $51.04 million.

  • Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of 11.5% (FY2020 to FY2025).
  • Across earlier years, Net Equity Issued and Repurchased came in at $560,000 in FY2024 (+93.8%), $289,000 in FY2023 (-72.4%), $1.05 million in FY2022 (-88.4%) and $9.01 million in FY2021 (-69.6%).
  • Quarterly Net Equity Issued and Repurchased has ranged from $1,000 in Q4 2024 to $44.1 million in Q1 2026 over the past five years.
  • Peak year-over-year performance for Net Equity Issued and Repurchased in the last five years was growth of 886.3% in Q1 2025, against a decline of 100.0% in Q3 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $44.1 million (Q1 2026), $29.02 million (Q4 2025) and $17.32 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 SELLAS Life Sciences 2.49 Bn 2.49 Bn - 38.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 38.82 Mn
Mar 31, 2026 44.10 Mn
Dec 31, 2025 29.02 Mn
Sep 30, 2025 17.32 Mn
Jun 30, 2025 4.21 Mn
Mar 31, 2025 503,000.00
Dec 31, 2024 1,000.00
Sep 30, 2024 155,000.00
Jun 30, 2024 353,000.00
Mar 31, 2024 51,000.00
Dec 31, 2023 21,000.00
Mar 31, 2023 268,000.00
Dec 31, 2022 929,000.00
Sep 30, 2022 69,000.00
Jun 30, 2022 3,000.00
Mar 31, 2022 47,000.00
Dec 31, 2021 5.99 Mn
Sep 30, 2021 2,000.00
Jun 30, 2021 17,000.00
Mar 31, 2021 3.00 Mn
API Access

SELLAS Life Sciences Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=SLS&period=max&api_key=YOUR_API_KEY